An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Better Therapeutics (NASDAQ: BTTX) announced it will release its Q1 2022 financial results before the market opens on May 13, 2022. A conference call for a business update will follow at 8:30 a.m. Eastern Time on the same day. The company specializes in prescription digital therapeutics aimed at addressing cardiometabolic diseases through nutritional cognitive behavioral therapy (nCBT). Their proprietary platform aims to create FDA-regulated solutions for conditions like type 2 diabetes and heart disease, which could enhance patient health and reduce healthcare costs.
Positive
None.
Negative
None.
SAN FRANCISCO--(BUSINESS WIRE)--
Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced it will release its first quarter 2022 financial results before the market opens on Friday, May 13, 2022. Management will host a conference call and webcast to provide a business update at 8:30 a.m. Eastern Time on Friday, May 13, 2022.
The conference call may be accessed by dialing (833) 945-2463 (domestic) or (678) 825-8211 (international) and referring to conference ID: 9776049. The live webcast may be accessed by visiting the event link at: https://edge.media-server.com/mmc/p/xqrnp5by. Following the webcast, a replay of the webcast may be accessed from the Presentations & Events page in the Investors section of the Better Therapeutics corporate website at: investors.bettertx.com.
About Better Therapeutics
Better Therapeutics is a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The cognitive behavioral therapy delivered by Better Therapeutics’ PDT is designed to enable changes in neural pathways of the brain so lasting changes in behavior become possible. Addressing the underlying causes of these diseases has the potential to dramatically improve patient health while lowering healthcare costs. Better Therapeutics clinically validated mobile applications are intended to be prescribed by physicians and reimbursed like traditional medicines.
When will Better Therapeutics release its Q1 2022 financial results?
Better Therapeutics will release its Q1 2022 financial results before the market opens on May 13, 2022.
What is the focus of Better Therapeutics?
Better Therapeutics focuses on developing prescription digital therapeutics that provide nutritional cognitive behavioral therapy to address the root causes of cardiometabolic diseases.
What time is the conference call for Better Therapeutics on May 13, 2022?
The conference call will take place at 8:30 a.m. Eastern Time on May 13, 2022.
How can I access the conference call and webcast for Better Therapeutics?
You can access the conference call by dialing (833) 945-2463 for domestic calls or (678) 825-8211 for international calls, using conference ID: 9776049. The live webcast can be accessed through their event link.
